Takeda Pharmaceutical Co. Newsletter
-
Rare Disease Therapeutics Market to hit US$ 495.27 billion by 2033, (CAGR 13.8%)
05 Dec 2025 07:50 GMT
… -La Roche Ltd, Novartis AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Sanofi …
-
Colorectal Cancer Drugs Market Competition Analysis 2025: How Players Are Shaping Growth
05 Dec 2025 01:30 GMT
… Inc., Pfizer Canada ULC, Takeda Pharmaceutical Company Limited, Novartis AG, … Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Chugai Pharmaceutical Co … region.
• South America: Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb …
-
Non-small cell lung cancer Market Competition Analysis 2025: How Players Are Shaping Growth
05 Dec 2025 00:15 GMT
… )
o Novartis AG (1%)
o Takeda Pharmaceutical Company Limited (1%)
Request a … , PT Etana Biotechnologies Indonesia, and Takeda Pharmaceutical Company Limited are some of …
-
Pharmaceutical Marketing Industry Trends and Emerging Opportunities 2025-2032 Featuring Syneos Health, McCann Health, Amgen, AXPIRA, Pfizer and More - ResearchAndMarkets.com
04 Dec 2025 16:51 GMT
…
Real Chemistry
Sciad Communications
Stramasa
Takeda Pharmaceutical Company Limited
Viseven Europe OU …
-
What Trends Are Defining the Hemophilia Inhibitors Market Growth?
04 Dec 2025 14:00 GMT
… Nordisk A/S (Denmark)
Takeda Pharmaceutical Company Limited (Japan)
Bayer AG …
-
Irritable Bowel Syndrome (IBS) Treatment Market Competition Analysis 2025: How Players Are Shaping Growth
04 Dec 2025 00:30 GMT
… Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Novartis AG … Limited, AstraZeneca plc, Takeda Pharmaceutical Company Limited, and Biocodex … Health Companies Inc., Takeda Pharmaceutical Company Limited, Abbott Laboratories …
-
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight
03 Dec 2025 23:21 GMT
… .12
ADYNOVATE (Adynovi; BAX 855): Takeda Pharmaceutical
11.13
AFSTYLA (Lonoctocog alfa …
-
Hyperphosphatemia Drugs Market Rising Demand to Drive 9.2% CAGR, Reaching USD 6.7 Billion by 2032 | CMI
03 Dec 2025 12:37 GMT
… Inc.
Otsuka Holdings Co., Ltd.
Takeda Pharmaceutical Company Limited
Key Developments
In …
-
Biologics Market Competition Analysis 2025: How Players Are Shaping Growth
03 Dec 2025 01:30 GMT
… Lifesciences Limited (formerly Zydus Cadila), Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company …
-
Oncology Market Size Worth USD 668.26 Billion by 2034
02 Dec 2025 15:27 GMT
… : Takeda Oncology, a subsidiary of Takeda Pharmaceutical Company, focuses its R…
About
© 1995-2025